US FDA working with global regulators to know scope of cough syrup contamination
PremiumAmid rising cases of cough syrup contamination in several countries, US FDA said it is working with global regulators and WHO to understand scope of cough syrup contamination
The U.S. Food and Drug Administration said on Wednesday it is working with the World Health Organization and foreign regulatory authorities to support an investigation into contaminated cough syrups that have killed nearly 300 children in Africa and Asia.
In a statement, the FDA said it had no indication that contaminated syrups had entered the U.S. drug supply chain, and it recommended consumers only take medicines which were made to be sold in the United States, especially for children.
Earlier this week, the WHO said it had expanded an inquiry into contaminated cough syrups linked to deaths in Gambia, Indonesia and Uzbekistan to four additional countries, and called on governments more widely to ensure that medicines for sale are approved by competent authorities.
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.
